{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T19:20:07Z","timestamp":1777922407192,"version":"3.51.4"},"reference-count":29,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Monoclonal Antibodies in Immunodiagnosis &amp; Immunotherapy"],"published-print":{"date-parts":[[2018,12,1]]},"abstract":"<jats:p>\n                    Breast cancer (BC) is a multistep disease that is thought to result from an interaction between genetic background and environmental factors. In Iran, one of the strongest risk factors for developing BC is a positive family history of the disease. Recently, various polymorphisms of E-cadherin (CDH1) and TERT have been found to be associated with increased BC risk worldwide. This study aimed to analyze the association of\n                    <jats:italic toggle=\"yes\">CDH1<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">TERT<\/jats:italic>\n                    single-nucleotide polymorphisms with susceptibility to familial BC (FBC) risk in the Iranian patients. One hundred five patients with FBC and 110 non-FBC (NFBC) were genotyped to elucidate the potential association between CDH1 rs5030625 polymorphism and\n                    <jats:italic toggle=\"yes\">TERT<\/jats:italic>\n                    rs2736098 polymorphism by polymerase chain reaction-restriction fragment length polymorphism. Then, results were evaluated by electrophoresis and Epi Info(\u2122) 2012 software. A significant association was found between\n                    <jats:italic toggle=\"yes\">CDH1<\/jats:italic>\n                    rs5030625 GAGA genotype and FBC risk. Compared with the control group, the FBC patients had a lower frequency of GG genotype (69% vs. 85%) and a higher frequency of GAGA (5% vs. 2%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2009&lt;\u20090.02). Furthermore, the patients with FBC had a lower frequency of\n                    <jats:italic toggle=\"yes\">TERT<\/jats:italic>\n                    rs2736098 GG genotype (38% vs. 49%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2009=\u20090.001) and a higher frequency of rs2736098 AA genotype (12% vs. 5%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2009=\u20090.001) compared with the NFBC. In contrast, the\n                    <jats:italic toggle=\"yes\">TERT<\/jats:italic>\n                    rs2736098 GG genotype potentially increased the recurring risk of FBC (odds ratio\u2009=\u20093.17,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2009&lt;\u20090.01). Allele genotypic frequencies in the FBC patients differed from those of the controls. Interestingly, tumors in FBC patients with rs2736098 GG genotype and rs5030625 GAGA exhibited higher mitotic activity, higher grade, lower estrogen receptor, and progesterone receptor than the other genotypes. In conclusion,\n                    <jats:italic toggle=\"yes\">CDH1<\/jats:italic>\n                    rs5030625 GAGA genotype and\n                    <jats:italic toggle=\"yes\">TERT<\/jats:italic>\n                    rs2736098 GG genotype in combination with clinical parameters may be prognostic factors rather than susceptibility factors during the progression of FBC.\n                  <\/jats:p>","DOI":"10.1089\/mab.2018.0017","type":"journal-article","created":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T10:58:13Z","timestamp":1544698693000},"page":"239-244","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of\n                    <i>CDH1<\/i>\n                    and\n                    <i>TERT<\/i>\n                    Single-Nucleotide Polymorphisms with Susceptibility to Familial Breast Cancer Risk"],"prefix":"10.1177","volume":"37","author":[{"given":"Mahsa","family":"Bagherpour","sequence":"first","affiliation":[{"name":"Islamic Azad University","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamelia","family":"Gharibzad","sequence":"additional","affiliation":[{"name":"Islamic Azad University","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Rassi","sequence":"additional","affiliation":[{"name":"Islamic Azad University","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2018,12,28]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21262"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2015.0081"},{"key":"e_1_3_2_4_2","first-page":"55","article-title":"Application of multiplex PCR with histopathologic features for detection of familial breast cancer in formalin-fixed, paraffin-embedded histologic specimens","volume":"42","author":"Rassi H","year":"2008","unstructured":"Rassi H, , Houshmand M, , Hashemi M, , Majidzadeh K, , Akbari MH, , and Panahi MS: Application of multiplex PCR with histopathologic features for detection of familial breast cancer in formalin-fixed, paraffin-embedded histologic specimens. Cyto Genet, 2008; 42:55\u201362.","journal-title":"Cyto Genet"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2017.0011"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-016-9869-5"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-4612-7"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1089\/gtmb.2012.0485"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/jso.21929"},{"key":"e_1_3_2_10_2","first-page":"5753","article-title":"Association between E-cadherin (CDH1) polymorphisms and pancreatic cancer risk in Han Chinese population","volume":"8","author":"Zhao L","year":"2015","unstructured":"Zhao L, , Wang YX, , Xi M, , Liu SL, , Zhang P, , Luo LL, , and Liu MZ: Association between E-cadherin (CDH1) polymorphisms and pancreatic cancer risk in Han Chinese population. Int J Clin Exp Pathol, 2015; 8:5753\u20135760.","journal-title":"Int J Clin Exp Pathol"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-016-1077-4"},{"key":"e_1_3_2_12_2","first-page":"421","article-title":"Correlation of a single nucleotide polymorphism in the E-cadherin gene promoter with tumorigenesis and progression of gastric carcinoma in Japan","volume":"23","author":"Kuraoka K","year":"2003","unstructured":"Kuraoka K, , Oue N, , Yokozaki H, , Kitadai Y, , Ito R, , Nakayama H, , and Yasui W: Correlation of a single nucleotide polymorphism in the E-cadherin gene promoter with tumorigenesis and progression of gastric carcinoma in Japan. Int J Oncol, 2003; 23:421\u2013427.","journal-title":"Int J Oncol"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc822"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgh073"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2050.2007.00724.x"},{"key":"e_1_3_2_16_2","first-page":"1696","article-title":"Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis","volume":"53","author":"Oka H","year":"1993","unstructured":"Oka H, , Shiozaki H, , Kobayashi K, , Inoue M, , Tahara H, , Kobayashi T, , Takatsuka Y, , Matsuyoshi N, , Hirano S, , Takeichi M, , and Mori T: Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res, 1993; 53:1696\u20131701.","journal-title":"Cancer Res"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/105.4.394"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01092751"},{"key":"e_1_3_2_19_2","first-page":"2776","article-title":"Abnormal expression of serum soluble E-cadherin is correlated with clinicopathological features and prognosis of breast cancer","volume":"20","author":"Liang Z","year":"2014","unstructured":"Liang Z, , Sun XY, , Xu LC, , and Fu RZ: Abnormal expression of serum soluble E-cadherin is correlated with clinicopathological features and prognosis of breast cancer. Med Sci Monit, 2014; 20:2776\u20132782.","journal-title":"Med Sci Monit"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2013.06.010"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/35000025"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2009.04.051"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2012.1611"},{"key":"e_1_3_2_24_2","first-page":"423","article-title":"Telomeres and telomerase in human cancer (review)","volume":"7","author":"Bacchetti S","year":"1995","unstructured":"Bacchetti S, , and Counter C: Telomeres and telomerase in human cancer (review). Int J Oncol, 1995; 7:423\u2013432.","journal-title":"Int J Oncol"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24363"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgn099"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603934"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djs222"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.985"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.22056"}],"container-title":["Monoclonal Antibodies in Immunodiagnosis &amp; Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/mab.2018.0017","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mab.2018.0017","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mab.2018.0017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:19:47Z","timestamp":1777666787000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/mab.2018.0017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,1]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12,1]]}},"alternative-id":["10.1089\/mab.2018.0017"],"URL":"https:\/\/doi.org\/10.1089\/mab.2018.0017","relation":{},"ISSN":["2167-9436","2167-9436"],"issn-type":[{"value":"2167-9436","type":"print"},{"value":"2167-9436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,1]]}}}